The Co-Evaluation of Ovarian Epithelium Karyorrhexis and Oophoritis after the Erythropoietin Effect on Ovarian Ischemia Reperfusion Injury
Abstract
Aim: This study co-evaluated the 2 quoted histologic variables after the erythropoietin (Epo) administration.
The calculation was based on the results of 2 preliminary studies, each one evaluating a respective histologic
variable of ovarian epithelium karyorrhexis (OK) or oophoritis (OI) in an induced ischemia reperfusion animal
experiment.
Materials and Methods: The 2 main experimental endpoints at which the OK and OI scores were evaluated was
the 60th reperfusion min(for the groups A and C) and the 120th reperfusion min (for the groups B and D). Specially,
the groups A and B were processed without drugs, whereas the groups C and D after Epo administration.
Results: The first preliminary study showed that Eponon significantly recessed the ovarian epithelium
karyorrhexis (OK) within the “without lesions alterations” grade by 0.0818182 [-0.2159977 - 0.0523614]
(p-value=0.2246)1. However, the second preliminary study showed that Epo significantly enhanced oophoritis
(OI) within the “without lesions alterations” grade by 0.1363636 [0.0421443 - 0.230583] (p-value=0.0057)2.
These 2 studies were co-evaluated since they came from the same experimental setting. This study investigated
the combined diagnostic value of both variables together.
Conclusions: Epo has a hardly deteriorating potency of these histologic parameters within the “without lesions
alterations” grade by 0.0272727 [-0.0556778 - +0.1102233] (p-value=0.5097) since they were co-evaluated
together.